Older males recovering from COVID-19 may have best plasma to treat it
ISLAMABAD, October 26 (online): A new study has found higher numbers of anti-SARS-CoV-2 antibodies in older males who required hospitalization for COVID-19.
Scientists have found that being hospitalized with COVID-19, as well as being male and of older age, increases the chances of a person having high plasma levels of antibodies that can protect against the disease.
This plasma, which is a component of blood, may help treat the disease in others.
As scientists continue to search for an effective vaccine for SARS-CoV-2, the virus that causes COVID-19, treatments that can reduce the risk of death are crucial for lowering the mortality rate associated with the disease.
However, to date, research has shown few treatments to be effective.
Furthermore, a major study by the World Health Organization (WHO) — currently available as a preprint — found that remdesivir, the most promising treatment for COVID-19, appears to make no significant difference to the mortality rate.
One possible treatment that may be effective is antibody therapy through convalescent plasma infusion.